High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-06-15
著者
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
小嶋 哲人
Department Of Transfusion Medicine Cardiology And Hematology Nagoya University Hospital
-
小嶋 哲人
名古屋大学医学部第一内科
-
小嶋 哲人
名古屋大学 保健
-
MATSUSHITA Tadashi
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
SAITO Hidehiko
Nagoya Central Hospital
-
KOJIMA Tetsuhito
Department of Medical Technology, Nagoya University School of Health Sciences
-
NISHIDA Tetsuya
Department of Internal Medicine, Japanese Red Cross Nagoya First Hospital
-
ITO Masafumi
Department of Pathology, Japanese Red Cross Nagoya Daiichi Hospital
-
MURATA Makoto
Department of Materials Engineering Science, Graduate School of Engineering Science, Osaka Universit
-
Yokozawa Toshiya
豊橋市民病院 血液･腫瘍内科
-
Yokozawa Toshiya
Clinical Research Center National Hospital Organization Nagoya Medical Center
-
Yokozawa T
Nagoya Univ. Graduate Schol Of Medicine Nagoya Jpn
-
Yokozawa T
Hematology Division National Cancer Center Hospital
-
Yokozawa Toshiya
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Yokozawa Toshiya
Division Of Hematology Nagoya Medical Center
-
Saito H
Department Of Hematology Meitetsu Hospital
-
Sakamaki Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Hiraoka Sakamaki
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
KATSUMI Akira
Department of Hematology-Oncology, Nagoya University Graduate School of Medicine
-
KOSUGI Hiroshi
Department of Hematology, Ogaki Municipal Hospital
-
Kojima Tetsuhito
名古屋市立大学 医学系研究科血液腫瘍内科学
-
Kiyoi Hitoshi
豊橋市民病院 血液･腫瘍内科
-
Kosugi H
Department Of Hematology Ogaki Municipal Hospital
-
Katsumi A
Department Of Hematology-oncology Nagoya University Graduate School Of Medicine
-
Katsumi Akira
名古屋市立大学 医学系研究科血液腫瘍内科学
-
Nishida Tetsuya
Department Of Internal Medicine Japanese Red Cross Nagoya First Hospital
-
Saito H
Nagoya Central Hospital
-
Soda Hisashi
Department Of Hematology Tokyo Metropolitan Komagome Hospital
-
Soda Hisashi
Department Of Internal Medicine Isahaya Insurance General Hospital
-
HIRASHIMA Kanji
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
ADACHI Tatsuya
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
ICHIHASHI Ryoichi
Department of Pathology, Nagoya University Hospital
-
INUKAI Akira
Department of Neurology, Nagoya University Graduate School of Medicine
-
HAYASHI Mutsuharu
Division of Cardiology, Nagoya Medical Center
-
Katsumi Akira
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Ito Masafumi
Department Of Pathology Japanese Red Cross Nagoya First Hospital
-
Takemoto Yoshinobu
Department Of Pathology Okayama University Medical School
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
Hayashi Mutsuharu
Division Of Cardiology Nagoya Medical Center
-
Ito Masafumi
Department Of Hematology Yamanashi Prefectural Central Hospital
-
Nishida Tetsuya
Department Of Bioengineering Nagaoka University Of Technology
-
Inukai Akira
Department Of Neurology Nagoya University Graduate School Of Medicine
-
Adachi Tatsuya
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Adachi Tatsuya
Department Of Hematology And Oncology Toyohashi Municipal Hospital
-
Kosugi Hiroshi
Institute For Chemical Research Tohoku University
-
Ichihashi Ryoichi
Department Of Cardiology Toki General Hospital
-
Ichihashi Ryoichi
Department Of Pathology Nagoya University Hospital
-
Murata M
Japan Marrow Donor Program Marrow Transplant Promotion Foundation Data And Sample Management Committ
-
Saito H
Nagoya National Hospital Nagoya Jpn
-
Kojima Tetsuhito
Department Of Internal Medicine Nagoya University School Of Medicine
-
Sakamaki Hisashi
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Sakamaki H
Tokyo Metropolitan Komagome Hospital Tokyo Jpn
-
Kojima Tetsuhito
Department Of Transfusion Medicine Cardiology And Hematology Nagoya University Hospital
-
Matsushita Tadashi
Department Of Applied Physics Faculty Of Engineering Nagoya University
-
Saito Hidehiko
Nagoya Central Hospital Nagoya Jpn
-
Murata Makoto
Department Of Chemical Science And Engineering Graduate School Of Engineering Science Osaka Universi
-
Kaname Tadashi
Depatment Of Developmental Genetics Institute Of Molecular Embryology And Genetics Kumamoto Universi
-
Inoue Masakazu
Department Of Pathology Japanese Red Cross Nagoya First Hospital
-
Ito Masafumi
Department Of Electrical And Electronic Engineering Faculty Of Science And Technology Meijo Universi
-
Suzuki Hideyoshi
Division Of Hematology Tokyo Metropolitan Komagome Hospital
-
Shishido Hideo
Third Department Of Internal Medicine Dokkyo University School Of Medicine
-
Murata Makoto
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Sakamaki Hisashi
Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital
-
Nishida Tetsuya
Department Of Bacteriology Hiroshima University Graduate School Of Biomedical Sciences
-
Nishida Tetsuya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Hirashima Kanji
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Kimura T
Peptide Inst. Inc. Osaka Jpn
-
ITO Masafumi
Department of Pathology, Japanese Red Cross, Nagoya First Hospital
関連論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- 白血病細胞株を用いた巨核芽球系分化誘導モデルにおけるヒトスフィンゴシンキナーゼ1発現機序の解析
- Long-PCR 法を用いた血液凝固第 VIII 因子 遺伝子の逆位解析
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Stress-induced PAI-1 expression is suppressed by pitavastatin in vivo
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Mutated RAS Induced PLD1 Gene Expression through Increased Sp1 Trascription Factor
- Recurrent Mutations of Factor XI Gene in Japanese
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- ジーンターゲティングを用いた血液凝固制御因子の生体における機能解明 : マウスantithrombinの完全欠損による胎児死亡とsyndecan-4欠損による胎盤迷路層胎児血管の変性
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- 教育シンポジウム:がんの遺伝子診断 PCRを用いた遺伝子診断の原理と応用-血友病Bを例にして-
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- 先天性凝固阻止因子欠乏症(antithrombin, protein C, protein S 欠損症)
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- AT/DS併用によるエンドトキシン誘発臓器傷害の改善効果 : Antithrombin/danaparoid sodium の抗凝固薬としての位置付け
- Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
- Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
- Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor
- Optimization of the Oxidative Folding Reaction and Disulfide Structure Determination of Multiple-Cystine Peptides
- Modifications Associated with Use of the Benzyloxymethyl Group on Histidine
- Chemical Synthesis of Human β-Defensin (hBD)-1,2,3 and 4 : Optimization for Folding Reduced hBDs into a Native Conformation
- Synthesis and Disulfide Structure Determination of Muscarinic Toxin 3
- Synthesis of Amyloid β-Peptides by Employing a Convergent Solid-Phase Approach Performed in a Mixture of Chloroform and Phenol
- Synthesis and Disulfide Structure Determination of Kurtoxin, a T-type Calcium Channel Blocker
- Synthesis of Prokineticin 2 by Solid-Phase Approach Performed in a Chloroform-Phenol Mixed Solvent
- Synthesis of Human Leptin Employing a Combined Solid-Phase and Solution Approach
- Optimization of Segment Condensation Reactions of Sparingly Soluble Protected Peptides in Chloroform-Phenol Mixed Solvent
- Side Reaction Associated with Use of N^in-Cyclohexyloxy- carbonyl (Hoc) Group for Tryptophans during HF Deprotection
- Synthesis of Muscarinic Toxin 1 and 7 Possessing High Specificity for Muscarinic Acetylcholine Receptor Subtype
- Amino Acid Deletion Products Resulting from Incomplete Deprotecion of the Boc Group during Solid-Phase Peptide Synthesis
- Synthesis of Amyloid β-Peptides in Solution : Chloroform- Phenol Mixed Solvent Is Essential for Segment Condensation of Sparingly Soluble Protected Peptides
- New Powerful Solvent System, A Mixture of Chloroform and Phenol, for Segment Condensation of Sparingly Soluble Protected Petides
- Total Synthesis of Aequorea Green Fluorescent Protein
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Genetic Abnormalities of Bernard-Soulier Syndrome
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Synthesis of Marinostatin, an Ester-Linked Protein Protease Inhibitor from the Marine Bacterium Pseudoalteromonas sagamiensis
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Guest editorial : Introducing progress in hematology in this issue